Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-024582

President and CEO bought 8,710 shares at $5.68 ($49,483)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brady Todd C President and CEO 2019-09-30 Purchase +8,710 $5.68 $49,483 632,216 D
Open-market purchases · 8,710 sh · avg $5.68 · $49,483
Loading xslF345X03/doc4.xml…